Lebanese Minister of Public Health Rakan Nasser El-Din announced the launch of the National Pharmacovigilance Campaign through an electronic tool that allows doctors and pharmacists to report adverse drug effects or patients' lack of benefit from medicines. This came at a press conference attended by a WHO representative and the heads of the doctors' and pharmacists' syndicates, where the minister revealed that a draft of updated criteria for registering biological and biosimilar drugs is being prepared in cooperation with the organization.